These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines. Mastroeni P, Villarreal-Ramos B, Hormaeche CE. Microb Pathog; 1992 Dec; 13(6):477-91. PubMed ID: 1363824 [Abstract] [Full Text] [Related]
8. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains. Zhang X, Kelly SM, Bollen W, Curtiss R. Microb Pathog; 1999 Mar; 26(3):121-30. PubMed ID: 10089152 [Abstract] [Full Text] [Related]
9. The potential Salmonella aroA- vaccine strain is safe and effective in young BALB/c mice. Burns-Guydish SM, Zhao H, Stevenson DK, Contag CH. Neonatology; 2007 Mar; 91(2):114-20. PubMed ID: 17344661 [Abstract] [Full Text] [Related]
14. Identification of three highly attenuated Salmonella typhimurium mutants that are more immunogenic and protective in mice than a prototypical aroA mutant. Valentine PJ, Devore BP, Heffron F. Infect Immun; 1998 Jul; 66(7):3378-83. PubMed ID: 9632608 [Abstract] [Full Text] [Related]
15. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Mastroeni P, Villarreal-Ramos B, Hormaeche CE. Infect Immun; 1993 Sep; 61(9):3981-4. PubMed ID: 8359920 [Abstract] [Full Text] [Related]
16. Mice vaccinated with a non-virulent, aromatic-dependent mutant of Salmonella choleraesuis die from challenge with its virulent parent but survive challenge with Salmonella typhimurium. Nnalue NA. J Med Microbiol; 1990 Apr; 31(4):225-33. PubMed ID: 2139129 [Abstract] [Full Text] [Related]
17. Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model. Harrison JA, Villarreal-Ramos B, Mastroeni P, Demarco de Hormaeche R, Hormaeche CE. Immunology; 1997 Apr; 90(4):618-25. PubMed ID: 9176117 [Abstract] [Full Text] [Related]
18. Occurrence of secondary attenuating mutations in avirulent Salmonella typhimurium vaccine strains. Lockman HA, Curtiss R. J Infect Dis; 1990 Dec; 162(6):1397-400. PubMed ID: 2230273 [Abstract] [Full Text] [Related]
19. Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset responses and protection against leishmanial challenge. Soo SS, Villarreal-Ramos B, Anjam Khan CM, Hormaeche CE, Blackwell JM. Infect Immun; 1998 May; 66(5):1910-7. PubMed ID: 9573069 [Abstract] [Full Text] [Related]
20. Immunosuppression and nitric oxide production induced by parenteral live Salmonella vaccines do not correlate with protective capacity: a phoP::Tn10 mutant does not suppress but does protect. Eisenstein TK, Meissler JJ, Miller SI, Stocker BA. Vaccine; 1998 Jan; 16(1):24-32. PubMed ID: 9607005 [Abstract] [Full Text] [Related] Page: [Next] [New Search]